Provider of biotechnological research services intended to detect mitochondrial injury. The company's services are primarily focused on predictive toxicology, tumor targeting and mitochondrial targeting and offers compounds screening on isolated mitochondria from healthy tissues and tumor cells.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | Completed | Generating Revenue |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-8809346-B2 | Ant-ligands molecules and biological applications | Active | 30-May-2008 | 0000000000 | 0 |
US-20110086865-A1 | Ant-ligands molecules and biological applications | Granted | 30-May-2008 | 0000000000 | 0 |
JP-2011521941-A | Ant-ligand molecules and biological applications | Pending | 30-May-2008 | 0000000000 | 00 |
JP-6383774-B2 | Ant-ligand molecules and biological applications | Active | 30-May-2008 | 0000000000 | |
EP-2334380-A1 | Anti-ligands molecules and biological applications | Granted | 30-May-2008 | C07D495/04 | 0 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Agoranov | Accelerator/Incubator | 000 0000 | 000000 0 |